3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lymphoma, Non-Hodgkin
1
Influenza, Human
1
Interventions
Influenza Vaccines
13
trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine
2
Vaccines
2
Oseltamivir
2
FluMist
2
Cyclophosphamide
2
vaxigrip
1
thymoglobulin
1
peginterferon alfa-2a
1
influvac
1
fludarabine
1
baloxavir
1
Starch
1
SARS-CoV-2 inactivated vaccines
1
Rituximab
1
Nivolumab
1
Melphalan
1
Levetiracetam
1
Lenalidomide
1
Ipilimumab
1
Interferons
1
Interferon alpha-2
1
Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Fluzone High-Dose
1
Diphtheria-Tetanus Vaccine
1
Celecoxib
1
Busulfan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Influenza, Human
×
influvac
×
Clear all
NCT01707628
2014-01-31
Rituxivac
St. Antonius Hospital
Phase NA
Completed
98 enrolled